What does the company do?
Pfizer Inc. (Pfizer) is a research-based, global pharmaceutical company. The Company discovers, develops, manufactures and markets prescription medicines for humans and animals. It operates in two business segments: Pharmaceutical and Animal Health. Pfizer also operates several other businesses, including the manufacture of gelatin capsules, contract manufacturing and bulk pharmaceutical chemicals. In June 2008, Pfizer completed the acquisition of all remaining outstanding shares of common stock of Encysive Pharmaceuticals, Inc. through a merger of Pfizer's wholly owned subsidiary, Explorer Acquisition Corp., with and into Encysive. In June 2008, it also completed the acquisition of Serenex, Inc., a biotechnology company with a Heat Shock Protein 90 development portfolio. In July 2009, Pfizer bought back a 29.52% stake in its Indian arm, Pfizer Limited, increasing its stake to 70.75%.In October 2009, Pfizer Inc. acquired Wyeth.
How much does the company sell and earn?
Investors need to know how much stuff or services a company sells, and how much of that total it keeps as income (or profit) to grow its business or return to shareholders. The more of each, the better. In general, look for companies that sell and earn more than peers.
- Pfizer one-year sales: 45.82 Bil.
Difference from the average for the Drug Manufacturers - Major group: 9.57% - Pfizer one-year income: 8.09 Bil.
Difference from the average for the Drug Manufacturers - Major group: 8.57%| Sales & Income (past 12 months) | Company | Industry |
|---|
| Sales | 45.82 Bil | 41.82 Bil | | Income | 8.09 Bil | 7.45 Bil |
How fast is the company growing?
- Pfizer one-year sales growth: -6.90%.
- Pfizer one-year income growth: 0.80%.
Difference from the average for the Drug Manufacturers - Major group: -4.50 pct. pts.| Sales & Income Growth (past 12 months) | Company | Industry |
|---|
| Sales Growth | -6.90% | 1.40% | | Income Growth | 0.80% | 5.30% |
How profitable is the company?
Investors prefer companies that increase profit margins -- the percentage of sales that they keep -- every year. This is accomplished either by lowering expenses or raising prices. Look for companies that consistently find ways to squeeze more profits out of sales than their peers.
- Pfizer one-year net profit margin: 17.7%
Difference from the company's 5-year average net profit margin: -1.3 pct. pts.
Difference from the average for the Drug Manufacturers - Major group: -1.0 pct. pts.
| Net profit margins (%) |
|---|
| Company | 17.7% | | Company 5-Yr Avg. | 19.0% | | Industry | 18.6% |
How is the company's financial health?
The debt/equity ratio shows how much a firm has borrowed as a percentage of its stock equity. The lower, the better.
- Pfizer debt/equity ratio: 0.59.
Difference from the average for the Drug Manufacturers - Major group: -74.12%.
| | Company | Industry |
|---|
| Debt/equity ratio | 0.59 | 2.28 |
|
Recent News